Generated with Avocode.Line 2Line 3
RapidAI Announces $75 Million Growth Investment
MUSC Revolutionizing Stroke and Aneurysm Care with RapidAI
RapidAI Editorial Team | November 23, 2022

Hypoperfusion intensity ratio and CBV index as biomarkers to predict intracranial atherosclerotic stenosis-related LVO

Intracranial atherosclerotic stenosis (ICAS) is one of the main causes of large vessel occlusion (LVO). However, it is challenging to diagnose...
RapidAI Editorial Team | February 10, 2022

5 Questions for RapidAI’s Clinical Learning and Development Team Lead

We spoke with Debi Taylor, Program Director and former stroke coordinator, to learn how her team collaborates with our customers to provide...
Dr. Carolina Maier | December 17, 2021

A recap of key results from RapidAI’s 2021 stroke studies

Thrombolysis and mechanical thrombectomy have revolutionized acute ischemic stroke management in the last two decades. And new AI-powered...